[1]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[2]
|
赫捷, 赵平, 陈万青. 2011中国肿瘤登记年报:中国肿瘤登记年报[R]. 北京: 军事医学科学出版社, 2012.
|
[3]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30.
https://doi.org/10.3322/caac.21332
|
[4]
|
Schmidt, N., Peitz, U., Lippert, H. and Malfertheiner, P. (2005) Missing Gastric Cancer in Dyspepsia. Alimentary Pharmacology & Therapeutics, 21, 813-820. https://doi.org/10.1111/j.1365-2036.2005.02425.x
|
[5]
|
Sun, D., Cao, M., Li, H., He, S. and Chen, W. (2020) Cancer Burden and Trends in China: A Review and Comparison with Japan and South Korea. Chinese Journal of Cancer Research, 32, 129-139.
https://doi.org/10.21147/j.issn.1000-9604.2020.02.01
|
[6]
|
国家消化系疾病临床医学研究中心, 中华医学会消化内镜学分会, 中华医学会健康管理学分会, 等. 中国早期胃癌筛查流程专家共识意见(草案2017年, 上海) [J]. 中华消化内镜杂志, 2018, 35(2):77-83.
|
[7]
|
Agréus, L., Kuipers, E.J., Kupcinskas, L., Malfertheiner, P., Di Mario, F., Leja, M., et al. (2012) Rationale in Diagnosis and Screening of Atrophic Gastritis with Stomach-Specific Plasma Biomarkers. Scandinavian Journal of Gastroenterology, 47, 136-147. https://doi.org/10.3109/00365521.2011.645501
|
[8]
|
Kageyama, T. (2002) Pepsinogens, Progastricsins, and Prochymosins: Structure, Function, Evolution, and Development. Cellular and Molecular Life Sciences CMLS, 59, 288-306. https://doi.org/10.1007/s00018-002-8423-9
|
[9]
|
Kim, Y.J. and Chung, W.C. (2020) Is Serum Pepsinogen Testing Necessary in Population-Based Screening for Gastric Cancer? The Korean Journal of Internal Medicine, 35, 544-546. https://doi.org/10.3904/kjim.2020.139
|
[10]
|
Miki, K., Fujishiro, M., Kodashima, S. and Yahagi, N. (2010) Long-Term Results of Gastric Cancer Screening Using the Serum Pepsinogen Test Method among an Asymptomatic Middle-Aged Japanese Population. Digestive Endoscopy, 21, 78-81. https://doi.org/10.1111/j.1443-1661.2009.00839.x
|
[11]
|
王兵, 李鼎, 张光明, 陆云, 高光琦, 刘兴党. 上海地区健康体检人群血清胃蛋白酶原水平研究[J]. 检验医学, 2016, 13(2): 210-211.
|
[12]
|
Kitahara, F., Kobayashi, K., Sato, T., Kojima, Y., Araki, T. and Fujino, M.A. (1999) Accuracy of Screening for Gastric Cancer Using Serum Pepsinogen Concentrations. Gut, 44, 693-697. https://doi.org/10.1136/gut.44.5.693
|
[13]
|
Wang, T., Dangler, C., Chen, D., Goldenring, J.R., Koh, T., Raychowdhury, R., et al. (2000) Synergistic Interaction between Hypergastrinemia and Helicobacter Infection in a Mouse Model of Gastric Cancer. Gastroenterology, 118, 36-47. https://doi.org/10.1016/S0016-5085(00)70412-4
|
[14]
|
Miki, K. (2011) Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels—“ABC Method”. Proceedings of the Japan Academy, Series B, 87, 405-414.
https://doi.org/10.2183/pjab.87.405
|
[15]
|
Kishino, T., Oyama T., Tomori, A., Takahashi, A. and Shinohara, T. (2020) Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer. Internal Medicine, 59, 1473-1480.
https://doi.org/10.2169/internalmedicine.3521-19
|
[16]
|
Copps, J., Murphy, R.F. and Lovas, S. (2009) The Production and Role of Gastrin-17 and Gastrin-17-Gly in Gastrointestinal Cancers. Protein & Peptide Letters, 16, 1504-1518. https://doi.org/10.2174/092986609789839269
|
[17]
|
Sun, L., Tu, H., Liu, J., Gong, Y., Xu, Q., Jing, J., et al. (2014) A Comprehensive Evaluation of Fasting Serum Gastrin-17 as a Predictor of Diseased Stomach in Chinese Population. Scandinavian Journal of Gastroenterology, 49, 1164-1172. https://doi.org/10.3109/00365521.2014.950693
|
[18]
|
Kang, J.M., Kim, N., Yoo, J.Y., Park, Y.S., Lee, D.H., Kim, H.Y., et al. (2010) The Role of Serum Pepsinogen and Gastrin Test for the Detection of Gastric Cancer in Korea. Helicobacter, 13, 146-156.
https://doi.org/10.1111/j.1523-5378.2008.00592.x
|
[19]
|
Wang, X., Ling, L., Li, S., Qin, G., Cui, W., Li, X., et al. (2016) The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis. Medicine, 95, Article ID: e3599. https://doi.org/10.1097/MD.0000000000003599
|
[20]
|
朱春平, 赵建业, 申晓军, 钱维, 马颖才, 张硕, 等. 血清胃泌素-17联合胃蛋白酶原检测对胃癌诊断价值的多中心临床研究[J]. 中华消化内镜杂志, 2017, 34(1): 19-23.
|
[21]
|
朱春平. “中国早期胃癌筛查方案”国际研讨会成功举办[J]. 中华消化内镜杂志, 2015, 32(2): 85.
|
[22]
|
李梦颖, 张德庆, 陆绚, 陈卫昌. 两种血清学方法在胃癌及其癌前状态筛查中的价值[J]. 中华内科杂志, 2018, 57(12): 907-911.
|
[23]
|
Chen, X.Z., Zhang, W.K., Yang, K., Wang, L.L., Liu, J., Wang, L., et al. (2012) Correlation between Serum CA724 and Gastric Cancer: Multiple Analyses Based on Chinese Population. Molecular Biology Reports, 39, 9031-9039.
https://doi.org/10.1007/s11033-012-1774-x
|
[24]
|
Shimada, H., Noie, T., Ohashi, M., Oba, K. and Takahashi, Y. (2014) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. https://doi.org/10.1007/s10120-013-0259-5
|
[25]
|
Kim, J. H., Jun, K.H., Jung, H., Park, I.S. and Chin, H.M. (2014) Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-Fetoprotein, CA72-4, and CA125) in Gastric Cancer. Hepatogastroenterology, 61, 863-869.
|
[26]
|
Pesta, M., Kucera, R., Topolcan, O., Karlikova, M., Houfkova, K., Polivka, J., et al. (2019) Plasma MicroRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients. Cancers, 11, Article No. 864.
https://doi.org/10.3390/cancers11060864
|
[27]
|
Chen, C., Chen, Q., Zhao, Q., Liu, M. and Guo, J. (2017) Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer. Annals of Clinical & Laboratory Science, 47, 260-263.
|
[28]
|
Jing, R., Cui, M., Ju, S. and Pan, S. (2020) The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer. Clinical Laboratory, 66. https://doi.org/10.7754/Clin.Lab.2019.190732
|
[29]
|
Mattar, R., Alves de Andrade, C.R., DiFavero, G.M., Gama-Rodrigues, J.J. and Laudanna, A.A. (2002) Preoperative Serum Levels of ca 72-4, cea, ca 19-9, and Alpha-Fetoprotein in Patients with Gastric Cancer. Revista do Hospital das Clínicas, 57, 89-92. https://doi.org/10.1590/S0041-87812002000300001
|
[30]
|
Cheng, S., Han, F., Wang, Y., Xu, Y., Qu, T., Ju, Y. and Lu, Z. (2017) The Red Distribution Width and the Platelet Distribution Width as Prognostic Predictors in Gastric Cancer. BMC Gastroenterology, 17, Article No. 163.
https://doi.org/10.1186/s12876-017-0685-7
|
[31]
|
Diakos, C.I., Charles, K.A., Mcmillan D.C. and Clarke, S.J. (2014) Cancer-Related Inflammation and Treatment Effectiveness. Lancet Oncology, 15, e493-e503. https://doi.org/10.1016/S1470-2045(14)70263-3
|
[32]
|
Schreiber, Robert, D., Old, L.J. and Smyth, M.J. (2011) Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Supression and Promotion. Science, 331, 1565-1570. https://doi.org/10.1126/science.1203486
|
[33]
|
Miyamoto, R., Inagawa, S., Sano, N., Tadano, S., Adachi, S. and Yamamoto, M. (2018) The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Short-Term and Long-Term Outcomes in Gastric Cancer Patients. European Journal of Surgical Oncology, 44, 607-612. https://doi.org/10.1016/j.ejso.2018.02.003
|
[34]
|
Queen, M.M., Ryan, R.E., Holzer, R.G., Keller-Peck, C.R. and Jorcyk, C.L. (2005) Breast Cancer Cells Stimulate Neutrophils to Produce Oncostatin M: Potential Implications for Tumor Progression. Cancer Research, 65, 8896-8904.
https://doi.org/10.1158/0008-5472.CAN-05-1734
|
[35]
|
Na, Y.K., Chun, D.H., Kim, S.Y., Kim, N.K., Baik, S.H., Hong, J.H., et al. (2019) Prognostic Value of Systemic Inflammatory Indices, NLR, PLR, and MPV, for Predicting 1-Year Survival of Patients Undergoing Cytoreductive Surgery with HIPEC. Journal of Clinical Medicine, 8, Article No. 589. https://doi.org/10.3390/jcm8050589
|
[36]
|
Lin, J.X., Wang, Z.K., Huang, Y.Q., Xie, J.W., Wang, J.B., Lu, J., et al. (2020) Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer. Journal of Gastrointestinal Surgery, 25, 387-396. https://doi.org/10.1007/s11605-020-04523-8
|
[37]
|
Pietrzyk, U., Plewa, Z., Denisow-Pietrzyk, M., Zebrowski, R. and Torres, K. (2016) Diagnostic Power of Blood Parameters as Screening Markers in Gastric Cancer Patients. Asian Pacific Journal of Cancer Prevention, 17, 4433-4437.
|
[38]
|
Fang T., Wang Y., Yin X., Zhai, Z., Zhang, Y., Yang, Y., et al. (2020) Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer. Journal of Immunology Research, 2020, Article ID: 9146042.
https://doi.org/10.1155/2020/9146042
|
[39]
|
张亚东, 胡音音, 杨启. 外周血PLR,NLR检测对胃癌诊断与病程评估的价值[J]. 实用医药杂志, 2020, 37(9): 811-813+封3.
|
[40]
|
Jones, P.A. and Baylin S.B. (2002) The Fundamental Role of Epigenetic Events in Cancer. Nature Reviews Genetics, 3, 415-428. https://doi.org/10.1038/nrg816
|
[41]
|
Usui, G., Matsusaka, K., Mano, Y., Urabe, M., Funata, S., Fukayama, M., et al. (2020) DNA Methylation and Genetic Aberrations in Gastric Cancer. Digestion, 102, 25-32. https://doi.org/10.1159/000511243
|
[42]
|
Chen, X., Gole, J., Gore, A., He, Q., Lu, M., Min, J., et al. (2020) Non-Invasive Early Detection of Cancer Four Years before Conventional Diagnosis Using a Blood Test. Nature Communications, 11, Article No. 3475.
https://doi.org/10.1038/s41467-020-17316-z
|
[43]
|
Hashad, D., Elbanna, A., Ibrahim, A. and Khedr, G. (2016) Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer. Journal of Clinical Laboratory Analysis, 30, 1100-1105. https://doi.org/10.1002/jcla.21987
|
[44]
|
Watanabe, Y., Kim, H.S., Castoro, R.J., Chung, W., Estecio, M.R., Kondo, K., et al. (2009) Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric Washes. Gastroenterology, 136, 2149-2158. https://doi.org/10.1053/j.gastro.2009.02.085
|
[45]
|
Oishi, Y., Watanabe, Y., Yoshida, Y., Sato, Y., Hiraishi, T., Oikawa, R., et al. (2012) Hypermethylation of Sox17 Gene Is Useful as a Molecular Diagnostic Application in Early Gastric Cancer. Tumor Biology, 33, 383-393.
https://doi.org/10.1007/s13277-011-0278-y
|
[46]
|
Pengdu, Q.X. (2003) Methylation and Mutation Analysis of p16 Gene in Gastric Cancer. World Journal of Gastroenterology, 9, 423-426. https://doi.org/10.3748/wjg.v9.i3.423
|